Cite
APA Citation
Douglas, G., Harrison, C., Forsyth, C., Bennett, M., Stevenson, W., Hounsell, J., Ratnasingam, S., Ritchie, D., Ross, D. M., & Grigg, A. (2017). busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea. Leukemia & lymphoma, 58(1), 89–95. http://access.bl.uk/ark:/81055/vdc_100039035605.0x000020